Our advice products provide a critical assessment of relevant evidence to aid decision-making. They do not contain recommendations or hold the status of formal NICE guidance.
These are summaries of the best available evidence to inform local NHS planning and decision making, for selected new medicines, off-label use of licensed medicines and unlicensed medicines.
These can be used to:
inform national commissioning decisions about medicines, for example by NHS England
provide information for healthcare professionals to inform their decision-making and support the development and updating of local formularies
help inform the public about a medicine and condition to help them make decisions about the medicine
provide information about an unlicensed medicine or off-label use of a licensed medicine that is being considered when there are no suitable alternatives licensed for that situation.